Blood-based markers may reveal Alzheimer's disease ten years before symptoms show

Summary by Ground News

Researchers at the Karolinska Institutet in Sweden have found that a protein called GFAP can appear in blood samples of people who are in the very early stages of the neurodegenerative disease. The scientists said their findings could lead to earlier detection of the disease and help slow it down with drugs.

Published 5 months ago · Stockholm, Sweden

News Articles

More
Filters

All

Left

Center

Right

The Independent

Blood markers could help identify rare, inherited form of Alzheimer’s disease

Findings could lead to earlier detection of the disease

5 months ago·London, United Kingdom

Read Full Article

Independent.ie

Biomarkers discovered for rare form of ‘inherited’ Alzheimer’s disease

Scientists have discovered blood markers that could help identify people with a rare, inherited form of Alzheimer’s disease a decade before symptoms begin to appear.

5 months ago·Ireland

Read Full Article

Wales Online

Blood markers ‘may reveal rare form of Alzheimer’s 10 years before symptoms’

Researchers found that a protein called GFAP can appear in blood samples of people who are in the very early stages of the neurodegenerative disease

5 months ago

Read Full Article

Evening Standard

Blood markers ‘may reveal rare form of Alzheimer’s 10 years before symptoms’

Scientists hope their work could lead to earlier detection.

5 months ago·London, United Kingdom

Read Full Article

Irish Examiner

Blood markers ‘may reveal rare form of Alzheimer’s 10 years before symptoms’

The scientists said their findings, published in the journal Brain, could lead to earlier detection of the disease and help slow it down with drugs

5 months ago·Ireland

Read Full Article

Medical Xpress

Blood-based markers may reveal Alzheimer's disease ten years before symptoms show

Alzheimer's disease begins decades before the onset of any symptoms, such as memory loss. Consequently, early diagnosis increases the chances of slowing the disease down with drugs. A new study on an inherited form of the disease shows that a protein called GFAP is a possible biomarker for very early stages of the disease. The study, conducted by researchers at Karolinska Institutet and published in the journal Brain, could one day lead to an ea…

5 months ago

Read Full Article